GlaxoSmithKline Pharmaceuticals Limited (GLAXO) — Long-term Investment Intensity
GlaxoSmithKline Pharmaceuticals Limited (GLAXO) has a Long-term Investment Intensity of 0.0% as of September 2019. Long-term investments of Rs600.00K represent 0.0% of total assets of Rs35.20 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check GLAXO cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
GlaxoSmithKline Pharmaceuticals Limited Long-term Investment Intensity (2014–2019)
This chart shows how GlaxoSmithKline Pharmaceuticals Limited's Long-term Investment Intensity has evolved across 6 annual periods from 2014 to 2019. As of September 2019, the intensity stands at 0.0%, reflecting long-term investments of Rs600.00K against total assets of Rs35.20 Billion INR. Explore debt repayment capacity of GlaxoSmithKline Pharmaceuticals Limited to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for GlaxoSmithKline Pharmaceuticals Limited (2014–2019)
The table below presents the year-by-year Long-term Investment Intensity for GlaxoSmithKline Pharmaceuticals Limited from 2014 to 2019, covering 6 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see GlaxoSmithKline Pharmaceuticals Limited market capitalisation.
| Year | LT Investment Intensity | LT Investments (INR) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2019 | 0.0% | Rs550.00K | Rs39.11 Billion | ▲ +0.0 pp |
| 2018 | 0.0% | Rs550.00K | Rs39.47 Billion | ▼ 0.0 pp |
| 2017 | 0.0% | Rs550.00K | Rs30.04 Billion | ▲ +0.0 pp |
| 2016 | 0.0% | Rs550.00K | Rs30.46 Billion | ▼ 0.0 pp |
| 2015 | 0.0% | Rs695.00K | Rs32.24 Billion | ▲ +0.0 pp |
| 2014 | 0.0% | Rs550.00K | Rs31.30 Billion | — |